Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,076 | 61,031 | 68,905 | 81,220 | 145,831 |
| Receivables | 208,046 | 205,893 | 184,810 | 202,379 | 212,422 |
| Inventories | 92,283 | 89,347 | 92,969 | 94,391 | 100,533 |
| Other current assets | 75,154 | 80,999 | 79,159 | 78,339 | 89,466 |
| TOTAL | $451,559 | $437,270 | $425,843 | $456,329 | $548,252 |
| Non-Current Assets | |||||
| PPE Net | 727,405 | 740,225 | 738,030 | 728,887 | 743,450 |
| Intangibles | 280,795 | 289,336 | 290,998 | 305,740 | 315,457 |
| Other Non-Current Assets | 86,314 | 88,527 | 103,449 | 94,417 | 98,266 |
| TOTAL | $1,094,514 | $1,118,088 | $1,132,477 | $1,129,044 | $1,157,173 |
| Total Assets | $1,546,073 | $1,555,358 | $1,558,320 | $1,585,373 | $1,705,425 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 134,830 | 29,574 | 14,758 | 19,838 | 57,994 |
| Accounts payable and accrued liabilities | 34,487 | 32,353 | 34,332 | 34,622 | 33,092 |
| Accrued Expenses | 82,396 | 88,088 | 95,979 | 100,704 | 112,147 |
| Other current liabilities | 14,367 | 14,461 | 14,033 | 14,108 | 14,825 |
| TOTAL | $328,126 | $223,835 | $216,797 | $223,842 | $277,103 |
| Non-Current Liabilities | |||||
| Long Term Debt | 551,397 | 674,743 | 703,187 | 720,483 | 731,418 |
| Deferred Revenues | 60,993 | 58,195 | 56,530 | 54,570 | 59,045 |
| Other Non-Current Liabilities | 101,579 | 102,167 | 110,860 | 99,584 | 106,171 |
| TOTAL | $653,097 | $777,018 | $814,160 | $820,162 | $837,695 |
| Total Liabilities | $981,223 | $1,000,853 | $1,030,957 | $1,044,004 | $1,114,798 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,731 | 48,996 | 48,887 | 49,441 | 51,358 |
| Common Shares | 791 | 790 | 785 | 785 | 783 |
| Retained earnings | -408,689 | -439,157 | -465,596 | -492,711 | -511,509 |
| Other shareholders' equity | 4,274 | 14,982 | 6,253 | 27,518 | 40,342 |
| TOTAL | $564,850 | $554,505 | $527,363 | $541,369 | $590,627 |
| Total Liabilities And Equity | $1,546,073 | $1,555,358 | $1,558,320 | $1,585,373 | $1,705,425 |